Massachusetts S2555 mandates pharmacies to report insufficient naloxone supplies to the Department of Public Health.
Massachusetts S2555, introduced to prevent overdoses, requires retail pharmacies licensed under section 39 to notify the Department of Public Health if their supply of naloxone nasal spray is insufficient. This measure aims to ensure that naloxone, a medication used to reverse opioid overdoses, is readily available in pharmacies across the state.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.